Take a trial of UK to unlock this pageFind out more

Surgical Innovations

SUN 1.78p 0.1  4.4%
27/06/16 20.0k

Momentum
Relative Strength (%)
1m
3m
1yr
Volume Change (%)
10d v 3m
Price vs... (%)
52w High
50d MA
200d MA
vs.
market
vs.
industry
Growth & Value
Margin of Safety (beta)
Screens Passed 1
Balance Sheet · Income Statement · Cashflow Financial Summary
Year End 31st Dec 2010 2011 2012 2013 2014 2015 2016E 2017E CAGR / Avg
Revenue £m
Operating Profit £m
Net Profit £m
EPS Reported p
EPS Normalised p
EPS Growth %
PE Ratio x
PEG x
Profitability
Operating Margin %
ROA %
ROCE %
ROE %
Cashflow
Op. Cashflow ps p
Capex ps p
Free Cashflow ps p
Dividends
Dividend ps p
Dividend Growth %
Dividend Yield %
Dividend Cover x
Balance Sheet
Cash etc £m
Working Capital £m
Net Fixed Assets £m
Net Debt £m
Book Value £m
Average Shares m
Book Value ps p -21.9%

FINANCIAL BRIEF: For the fiscal year ended 31 December 2015, Surgical Innovations Group Plc revenues increased 36% to L5.5M. Net loss decreased 79% to L2M. Revenues reflect SI Brand segment increase of 42% to L4.2M, OEM segment increase of 52% to L1.2M, USA segment increase of 96% to L1.5M, United Kingdom segment increase of 26% to L1.9M, Rest of the World segment increase of 73% to L721K. Lower net loss reflects Unallocated segment loss decrease of 77% to L2.3M. more »

Health Trend
Bankruptcy Risk
  Earnings Manipulation Risk
Magic Formula Score  
D-
D-
Other Ratios
Leverage (ttm) Total Ex Intang
Gross Gearing %
Net Gearing %
Cash / Assets %
vs.
market
vs.
industry
Recent History
Latest interim period (ended 31st Dec '15) vs. prior year
Sales Growth %
EPS Growth %
3yr Compound Annual Growth Rate
Sales Growth %
EPS Growth %
DPS Growth %

Broker Forecasts
31st Dec 2016
31st Dec 2017

Price Target: N/A
Net Profit EPS DPS Net Profit EPS DPS
Est. Long Term Growth Rate: n/a (£) (p) (p) (£) (p) (p)
Consensus Estimate
1m Change
3m Change
Broker Consensus Trend
Broker Recommendations for Surgical Innovations
Recommendation:Strong SellSellHoldBuyStrong Buy
No. of Analysts:

Named Brokers and Analysts
WH Ireland , Panmure Gordon , Sanlam Securities UK , Hume Capital Timothy Freeborn ,

Profile Summary

Surgical Innovations Group plc is a United Kingdom-based holding company. The Company is involved in the design, development, manufacture and sale of devices for use in minimally invasive surgery (MIS) and precision engineering (PE) markets. The Company operates through three segments: SI Brand, OEM and PE. The SI Brand segment is engaged in the research, development, manufacture and distribution of SI branded minimally invasive devices. The OEM segment includes the research, development, manufacture and distribution of minimally invasive devices for third-party medical device companies through either own label or co-branding. The PE segment is engaged in the research, development, manufacture and sale of precision engineering applications. The Company sells branded products through independent healthcare distributors across the world and owns label products through original equipment manufacturer (OEM) relationships.

Directors: Nigel Rogers (CHM) 54, Melanie Ross (MDR) 35, Douglas Liversidge (NED) 78, Michael McMahon (NED) , Chris Rea (NED) ,

No. of Employees: 49 No. of Shareholders: n/a


Last Annual December 31st, 2015
Last Interim December 31st, 2015
Incorporated September 20, 1988
Shares in Issue 487,087,354
Free Float 298.1m (61.2%)
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index FTSE Aim All Share ,
Exchange London Stock Exchange (AIM)
Eligible for an ISA? a SIPP?

SUN Share Price Performance SUNQuote
1.78p
0.1  4.4%
Traded 3:15pm · Minimum 15 min delayed · NMS: 20.0k

Latest SUN News Announcements (delayed)

Upcoming SUN Events

Recent ↓
Wednesday 22nd June, 2016 (estimate)
Surgical Innovations Group PLC Annual Shareholders Meeting
Wednesday 16th March, 2016
Full Year 2015 Surgical Innovations Group PLC Earnings Release
Tuesday 23rd June, 2015
Surgical Innovations Group PLC Annual Shareholders Meeting
Tuesday 18th November, 2014
Surgical Innovations Group Plc Secondary Public Offering Pricing


Use of our data service is subject to express Terms of Service. Please see our full site disclaimer for more details. In particular, it is very important to do your own research (DYOR) and seek professional advice before making any investment based on your own personal circumstances. Please note that the information, data and analysis contained within this stock report: (a) include the proprietary information of Stockopedia's third party licensors and Stockopedia; (b) should not be copied or redistributed except as specifically authorised; and (c) are not warranted to be complete, accurate or timely. You should independently research and verify any information that you find in this report. Stockopedia will not be liable in respect of any loss, trading or otherwise, that you may suffer arising out of such information or any reliance you may place upon it. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up. © Stockopedia 2016.


Should you buy SUN

Access SUN Analytics Now!

FREE TRIAL or TAKE THE TOUR
Let’s get you setup so you get the most out of our service
Done, Let's add some stocks
Brilliant - You've created a folio! Now let's add some stocks to it.

  • Apple (AAPL)

  • Shell (RDSA)

  • Twitter (TWTR)

  • Volkswagon AG (VOK)

  • McDonalds (MCD)

  • Vodafone (VOD)

  • Barratt Homes (BDEV)

  • Microsoft (MSFT)

  • Tesco (TSCO)
Save and show me my analysis
Foliobuilder